|
|
||||||||
RESEARCH REPORT |
1 Department of Pharmacology, 2 Dental Clinics, Unit of Periodontology, 3 Department of Clinical Chemistry and Laboratory Medicine, and 4 Institute of Epidemiology, Ernst Moritz Arndt University, F.-Loeffler-Str. 23d, D-17487 Greifswald, Germany;
* corresponding author, meiselp{at}unigreifswald.de
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: magnesium periodontitis epidemiology
| INTRODUCTION |
|---|
|
|
|---|
In the late 1980s, some observational studies suggested beneficial effects of magnesium on periodontitis. Such observations were made in patients receiving magnesium (Mg) for the treatment of tetanus syndrome (Kleber and Fehlinger, 1989), by measurement of magnesium (Mg) and calcium (Ca) concentrations in the blood of periodontitis patients (Meyle et al., 1987; Kuraner et al., 1991), as well as from the results of animal experiments (Kleber and Fehlinger, 1989).
Magnesium is one of the most abundant cations present in living cells. It is an essential mineral that is needed for a broad variety of physiological functions. Magnesium is considered the physiological calcium antagonist. At a cellular level, it may act as an important regulator of cell functions. Its serum concentration is remarkably constant in healthy subjects. High normal Mg serum concentrations are protective against various diseases (Laires et al., 2004). Imbalances in magnesium metabolism are common and are associated with different pathological conditions (Touyz, 2004). Recent studies suggest that periodontitis may be a risk factor for cardiovascular diseases (Scannapieco et al., 2003), which have also been associated with Mg deficiencies (Stalnikowicz, 2003).
A population-based cross-sectional health survey was performed in northeastern Germany (Study of Health in Pomerania [SHIP], N = 4290). The study assessed several diagnostic and anamnestic factors, among them the oral status of the participants. The a priori goal of this study was to identify risk indicators or risk determinants associated with periodontal disease. We report here the results of the population-based SHIP which suggest that the Mg/Ca ratio influences periodontal health.
| MATERIALS & METHODS |
|---|
|
|
|---|
|
Clinical Chemistry and Statistics
Determination of serum Mg was performed by atomic absorption spectroscopy, that of Ca by a colorimetric assay (Gindler and King, 1972), and that of HbA1C by a spectrophotometric method after cation-exchange chromatography (Tiran et al., 1994). Normal ranges were set at 0.751.05 and 2.252.69 mmol/L for Mg and Ca, respectively.
In a subpopulation, the subjects who consumed Mg-containing drugs were compared with two control persons matched for age, sex, smoking, and the level of education; these persons were selected from the total study. In this way, a 1:2 matched-pair study was established. It was not possible to have more than two subjects completely identical to the cases in all 4 variables (age, sex, smoking, education). If more than two controls were found, then the selection was by chance.
Since Mg and Ca exert opposite effects, we chose the ratio Mg/Ca as the critical determinant. Mg/Ca effects were analyzed by regression models. The percentage of sites
4 mm probing depth or
4 mm attachment loss was the dependent variable for the extent of periodontal disease.
We used ANOVA, multiple regression, and the Kruskal-Wallis or Mann-Whitney test to assess the significance of the magnesium effects on periodontal parameters. Statistical software STATVIEW® 5.0 (SAS, Cary, NC, USA) was used.
| RESULTS |
|---|
|
|
|---|
Magnesium and Periodontitisthe Total Population
In the first step, we classified all subjects according to quartile by Mg/Ca ratio and compared the two groups in the first (lowest) and fourth (upper) quartiles. We compared their periodontal status with respect to the extent of probing depth, attachment loss, and number of remaining teeth. In the Fig.
, the results are shown in dependence on the age of participants. Age is an important confounding factor for periodontitis. In the youngest group of subjects, there was no influence of Mg/Ca on probing depth or attachment loss (Fig., A,B
). In subjects aged 40 yrs and older, a higher Mg/Ca ratio was associated with a significantly lower level of periodontitis and, concomitantly, more remaining teeth. Maximum differences between low- and high-Mg/Ca groups were 7% and 13% for probing depth and attachment loss, respectively. Mean age with 50% tooth loss was 58.2 ± 1.0 and 61.1 ± 0.8 yrs in the low- and high-Mg/Ca quartiles, respectively. Dividing the 40- to 80-year-old subjects at the median of the Mg/Ca ratio resulted in means of the number of teeth of 13.6 ± 0.5 (95% C.I.) and 14.9 ± 0.5 (95% C.I.), for the low- and high-Mg/Ca groups, respectively (Mann-Whitney p < 0.001).
|
The subjects aged 40 to 80 yrs showed a significant correlation between the serum Mg concentrations and the periodontal parameters measured. These parameters were inversely related to the serum Ca concentration. However, there was no correlation between Mg and Ca levels. Therefore, we used the Mg/Ca ratio in serum to characterize this association. An increasing Mg/Ca ratio was associated with a decreasing level of probing depth or attachment loss and, correspondingly, an increasing number of remaining teeth (Fig. C
). Important covariates, viz., age, sex, smoking, education, and the percentage of HbA1C, were taken into account in multiple regression analyses. Probing depth (also attachment loss) was diminished with increasing Mg/Ca ratios, regardless of further inclusion of risk factors. ß-coefficients calculated in the multiple regression analyses showed significant associations of the known risk factors as well as of the Mg/Ca ratio with the parameters of chronic periodontitis (Table 2
). Female subjects had better periodontal health than males; however, paradoxically, they possessed, on average, fewer teeth than their male counterparts. The extent of periodontitis increased with age, and smoking was an important risk factor for, and a higher level of education a protective factor against, the disease. Glucose metabolism, characterized by HbA1c, was negatively associated with periodontitis and Mg metabolism as well. When the known risk factors for periodontitis were taken into account, the Mg/Ca ratio contributed significantly to the health state of the periodontium. This is indicated by a positive coefficient with the number of teeth and negative coefficients with respect to probing depth and attachment loss (Table 2
).
|
Subjects who reported using Mg-containing drugs displayed fewer signs of periodontal disease than their matched counterparts (Table 3
). Regardless of whether attachment loss, probing depth, or the number of remaining teeth was chosen as the criterion for periodontal disease, there were significant differences between the cases (Mg intake reported) and the matched controls (no Mg drugs). The median of the number of teeth was 17 and 14 in the cases group (Mg users) and control group (no Mg drugs), respectively.
|
| DISCUSSION |
|---|
|
|
|---|
Interactions between and among different steps in the pathogenesis of periodontitis may explain the relationship between periodontal status and the Mg/Ca ratio. Albeit still hypothetical, there are two lines of evidence for biologically plausible explanations.
Mg deficiency is also associated with low bone mass, which is manifested in the oral cavity as loss of alveolar crestal bone height and tooth loss, accompanied by the stimulation of pro-inflammatory cytokines (Wactawski-Wende, 2001). Daily oral Mg supplementation may have beneficial effects in reducing bone loss (Dimai et al., 1998). Additional risk factors affecting the Mg supply may contribute to these effects, as has been shown for subjects who smoke (Dyer et al., 2003).
In the matched-pair portion of our study, there was no difference in serum Mg levels between subjects taking Mg drugs and those who did not. Mg supplementation may influence intracellular processes without elevating the serum concentration, which is kept remarkably constant (Wactawski-Wende, 2001). An increase in serum Mg was attainable only by treating of hypomagnesemic subjects with very high amounts of Mg (Rodriguez-Moran and Guerrero-Romero, 2003).
In our study group, serum concentrations below 0.75 mmol/L were observed in 35% of subjects; in those between the ages of 20 and 40 yrs, the prevalence was even higher. These figures are higher than those described in comparable studies; however, an over-representation of young women was also observed in comparable studies (Schimatschek and Rempis, 2001). The association shown in this study could be a mere reflection of a healthy lifestyle, since the benefits of such a lifestyle may extend to periodontal health. Nevertheless, whenever symptoms of hypomagnesemia are obvious, sufficient supplementation is recommended. It may be achieved by an adequate diet rich in Mg, e.g., whole grain cereals, spinach, fish and seafood, nuts, and seeds. Further studies are necessary to address questions as to whether an adequate Mg supply in the young can alter the future risk of periodontitis in the elderly. At present, the same issue is under discussion with respect to cardiovascular diseases (Abbott et al., 2003), which are probably associated with periodontitis (Scannapieco et al., 2003).
Mg supplementation could prevent tooth loss in the middle-aged and delay tooth loss in the elderly. Thus, the well-being of the individual would be improved, and costs for prosthodontic treatment could be reduced.
Controlled randomized clinical trials, as well as studies of possible delivery mechanisms, are needed to evaluate the role of magnesium in the etiology of periodontal disease.
| ACKNOWLEDGMENTS |
|---|
Received October 8, 2004; Last revision May 6, 2005; Accepted June 18, 2005
| REFERENCES |
|---|
|
|
|---|
Albandar JM (2002). Global risk factors and risk indicators for periodontal diseases. Periodontol 2000 29:177206.
ATC Index (2003). WHO Collaborating Centre for Drug Statistics Methodology, Oslo. http://www.whocc.no/atcddd/
Bussiere FI, Gueux E, Rock E, Girardeau JP, Tridon A, Mazur A, et al. (2002a). Increased phagocytosis and production of reactive oxygen species by neutrophils during magnesium deficiency in rats and its inhibition by high magnesium concentrations. Br J Nutr 87:107113.[Medline]
Bussiere FI, Gueux E, Rock E, Mazur A, Rayssiguier Y (2002b). Protective effect of calcium deficiency on the inflammatory response in magnesium-deficient rats. Eur J Nutr 41:197202.[Medline]
Deas DE, Mackey SA, McDonell HT (2003). Systemic disease and periodontitis: manifestations of neutrophil dysfunction, Periodontol 2000 32:82104.
Dimai HP, Porta S, Wirnsberger G, Lindschinger M, Pamperl I, Dobnig H, et al. (1998). Daily oral magnesium supplementation suppresses bone turnover in young adult males. J Clin Endocrinol Metab 83:27422748.
Djurhuus MS (2001). New data on the mechanism of hypermagnesuria in type I diabetes mellitus. Magnes Res 14:217223.[Medline]
Dyer AR, Elliott P, Stamler J, Chan Q, Ueshima H, Zhou BF, INTERMAP Research Group (2003). Dietary intake in male and female smokers, ex-smokers, and never smokers: the INTERMAP study. J Hum Hypertens 17:641654.[Medline]
Genco RJ (1996). Current view of risk factors for periodontal diseases. J Periodontol 67(Suppl):10411049.[ISI][Medline]
Gindler EM, King JD (1972). Rapid colorimetric determination of calcium in biologic fluids with methylthymol blue. Am J Clin Pathol 58:376382.[Medline]
Guerrero-Romero F, Rodriguez-Moran M (2002). Low serum magnesium levels and metabolic syndrome. Acta Diabetol 39:209213.[ISI][Medline]
Heitz-Mayfield LJ, Schatzle M, Löe H, Burgin W, Anerud A, Boysen H, et al. (2003). Clinical course of chronic periodontitis. II. Incidence, characteristics and time of occurrence of the initial periodontal lesion. J Clin Periodontol 30:902908.[ISI][Medline]
Hensel E, Gesch D, Biffar R, Bernhardt O, Kocher T, Splieth C, et al. (2003). Study of Health in Pomerania (SHIP), a health survey in an east German region. Objectives and design of the oral health section. Quintessence Int 34:370378.[Medline]
Kleber BM, Fehlinger R (1989). Dental and periodontal disturbances due to magnesium deficit. Magnes Res 2:235237.[Medline]
Kuraner T, Beksac MS, Kayakirilmaz K, Caglayan F, Onderoglu LS, Ozgunes H (1991). Serum and parotid saliva testosterone, calcium, magnesium, and zinc levels in males, with and without periodontitis. Biol Trace Elem Res 31:4349.[Medline]
Laires MJ, Monteiro CP, Bicho M (2004). Role of cellular magnesium in health and human disease. Front Biosci 9:262276.[Medline]
Malpuech-Brugere C, Nowacki W, Daveau M, Gueux E, Linard C, Rock E, et al. (2000). Inflammatory response following acute magnesium deficiency in the rat. Biochem Biophys Acta 1501:9198.[Medline]
Meyle J, Heller W, Gotz H, Fuhrer G (1987). Plasma concentrations of calcium, magnesium, zink and copper in patients with marginal periodontitis [German]. Dtsch Zahnärztl Z 42:474479.[Medline]
Mooren FC, Golf SW, Volker K (2003). Effect of magnesium on granulocyte function and on the exercise induced inflammatory response. Magnes Res 16:4958.[Medline]
Rodriguez-Moran M, Guerrero-Romero F (2003). Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double- blind controlled trial. Diabetes Care 26:11471152.
Scannapieco FA, Bush RB, Paju S (2003). Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol 8:3853.[Medline]
Schimatschek HF, Rempis R (2001). Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 14:283290.[Medline]
Splieth C, Giesenberg J, Fanghanel J, Bernhardt O, Kocher T (2002). Periodontal attachment level of extractions presumably performed for periodontal reasons. J Clin Periodontol 29:514518.[Medline]
Stalnikowicz R (2003). The significance of routine serum magnesium determination in the ED. Am J Emerg Med 21:444447.[Medline]
Tiran A, Pieber T, Halwachs-Baumann G, Dobnig H, Grubelnig H, Wilders-Truschnig MM, et al. (1994). Automated determination of glycated hemoglobin: evaluation of five systems. J Clin Lab Anal 8:128134.[ISI][Medline]
Touyz RM (2004). Magnesium in clinical medicine. Front Biosci 9:12781293.[ISI][Medline]
Tsai C, Hayes C, Taylor GW (2002). Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 30:182192.[Medline]
Wactawski-Wende J (2001). Periodontal diseases and osteoporosis: association and mechanisms. Ann Periodontol 6:197208.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |